Between 2000 and 2024, more than 20,000 deaths recorded marijuana poisoning or a marijuana-related disorder as the underlying or contributing […]
“He wasn’t my happy child anymore. It was awful.” That’s how Texas mother Savannah Mallach describes watching her four-year-old son […]
A coalition of 35 Attorneys General, representing 34 states and the Virgin Islands, recently sent a letter urging Congress not […]
According to the National Survey on Drug Use and Health, the average number of days of use among past-year marijuana users aged […]
Thursday Edition of Friday Fact due to the July 4th Holiday: Federal data indicate that the vast majority of marijuana users use it exclusively as […]
The National Drug and Alcohol Screening Association presented a focused, credible case-in-chief on behalf of the drug and alcohol testing […]
Day three of the federal marijuana rescheduling hearing was dominated by the continued cross-examination of Dr. Cory Burchman, the retired […]
United Against Fentanyl, a DC-based drug policy organization, recently asserted that “in 2026, overdoses in the United States are at […]
A recent study in Lancet Psychiatry, which reviewed global data from 2000–2025, found that the commercialization of marijuana in the […]
This post is reprinted with permission from Sue’s Substack, by Sue Rusche. Raymond E. Bertino, MD, and colleagues at the Universities […]
The federal government’s second witness at the DEA marijuana rescheduling hearing came with a résumé that raised more questions than […]
A quiet bombshell dropped during the government witness’s testimony at the DEA marijuana rescheduling hearings over the past two days on marijuana […]
Thursday Edition of Friday Fact due to the July 4th Holiday: Federal data indicate that the vast majority of marijuana users use it exclusively as […]
The National Drug and Alcohol Screening Association presented a focused, credible case-in-chief on behalf of the drug and alcohol testing […]
Day three of the federal marijuana rescheduling hearing was dominated by the continued cross-examination of Dr. Cory Burchman, the retired […]
United Against Fentanyl, a DC-based drug policy organization, recently asserted that “in 2026, overdoses in the United States are at […]
A recent study in Lancet Psychiatry, which reviewed global data from 2000–2025, found that the commercialization of marijuana in the […]
This post is reprinted with permission from Sue’s Substack, by Sue Rusche. Raymond E. Bertino, MD, and colleagues at the Universities […]
The federal government’s second witness at the DEA marijuana rescheduling hearing came with a résumé that raised more questions than […]
A quiet bombshell dropped during the government witness’s testimony at the DEA marijuana rescheduling hearings over the past two days on marijuana […]